The global synovial sarcoma market is characterized by rising demand due to the boom in cases of this rare tumor. Key players are focusing on developing new treatments to address this life-threatening {condition|. The market is forecasted to expand at a substantial growth rate over the forecast period. Many factors are influencing this growth, such